Equities research analysts at Wedbush boosted their Q1 2025 earnings per share (EPS) estimates for Perspective Therapeutics ...
Investment analysts at Lifesci Capital issued their Q1 2025 earnings per share (EPS) estimates for shares of Perspective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results